PCM
EVH icon

Polymer Capital Management’s Evolent Health EVH Stock Holding History

Polymer Capital Management’s Portfolio EVH Stock Details EVH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-17,275
Closed -$194K – 535
2024
Q4 		$194K Buy
+17,275
New +$304K 0.05% 312

Other funds holding EVH

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CCM
Cadian Capital Management New York $821M AUM 14.36% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return
EC
Engaged Capital Newport Beach, California $303M AUM 2.09% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return

Polymer Capital Management's EVH Position: Q1 2025 in Review

Polymer Capital Management sold out of Evolent Health (EVH) in Q1 2025, closing a stake of 17,275 shares — an estimated $194K sold.

Polymer Capital Management first reported a position in EVH in Q4 2024 and held it in 1 quarter. The position peaked at $194K in Q4 2024. 227 funds tracked by Wall St. Rank hold EVH as of Q1 2025.

  • Polymer Capital Management reported no remaining Evolent Health position as of Q1 2025 after selling out during the quarter.
  • Polymer Capital Management sold 17,275 Evolent Health shares in Q1 2025, an estimated $194K.
  • Polymer Capital Management first reported a position in Evolent Health in Q4 2024 and held it in 1 quarter.
  • Polymer Capital Management's Evolent Health position peaked at $194K in Q4 2024.
  • 227 funds tracked by Wall St. Rank held Evolent Health as of Q1 2025.

Based on Polymer Capital Management's 13F filing for Q1 2025, filed 15 May 2025.